Funder
National Institute on Drug Abuse
Center for Medicinal Cannabis Research, University of California, San Diego
National Institute of General Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference183 articles.
1. Abraham AD, Leung EJY, Wong BA, Rivera ZMG, Kruse LC, Clark JJ, Land BB (2020) Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain. Neuropsychopharmacology 45(7):1105–1114
2. Administration SA, Mental Health S, O. o. t. S. General (2016) The neurobiology of substance use, misuse, and addiction. Facing addiction in America: The surgeon general's report on alcohol, drugs, and health [Internet], US Department of Health and Human Services
3. Agarwal K, Manza P, Chapman M, Nawal N, Biesecker E, McPherson K, Dennis E, Johnson A, Volkow ND, Joseph PV (2022) Inflammatory markers in substance use and mood disorders: a neuroimaging perspective. Front Psychiatry 13:863734
4. Akram H, Miller S, Lagrata S, Hyam J, Jahanshahi M, Hariz M, Matharu M, Zrinzo L (2016) Ventral tegmental area deep brain stimulation for refractory chronic cluster headache. Neurology 86(18):1676–1682
5. Alford DP, German JS, Samet JH, Cheng DM, Lloyd-Travaglini CA, Saitz R (2016) Primary care patients with drug use report chronic pain and self-medicate with alcohol and other drugs. J Gen Intern Med 31(5):486–491